» Articles » PMID: 32896972

Duodenal Microbiome in Patients with or Without Helicobacter Pylori Infection

Overview
Journal Helicobacter
Specialty Microbiology
Date 2020 Sep 8
PMID 32896972
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Intestinal microbiota are recognized as an organ with important physiological functions whose alterations have been associated with common diseases including inflammatory intestinal conditions, malnutrition, type-2 diabetes, and cardiovascular diseases. The composition and function of the microbiota in the distal part of the intestine has been mainly described, while there is limited information on the small intestine microbiota. The objective of the present study was to describe the duodenal microbiome in individuals with dyspepsia in the presence or absence of Helicobacter pylori gastric infection.

Materials And Methods: Thirty-eight biopsies from the proximal duodenum of uninfected and 37 from H pylori-infected individuals were analyzed. Microbiota composition was assessed by PCR amplification and sequencing of 16S rRNA and ITS genes; sequences were analyzed with QIIME2.

Results And Conclusions: At the phyla level, Proteobacteria, Bacteroidetes, Firmicutes, Actinobacteria, and Fusobacteria were predominant in the mucosal associated duodenal microbiota (MAM); at the genera level, we observed the predominance of Ralstonia, Streptococcus, Pseudomonas, Haemophilus, Herbaspirillum, Neisseria, and Veillonella. Microbiota α-diversity was higher in H pylori-infected individuals than in non-infected ones. In terms of β-diversity metrics, there was a statistically significant difference between groups. Also, relative abundance of Haemophilus, Neisseria, Prevotella pallens, Prevotella 7, and Streptococcus was greater in H pylori-infected patients. In infected patients, several types of H pylori were present in duodenal MAM. Finally, the majority of duodenal samples had fungi sequences; the most common taxa observed were Recurvomyces followed by Ascomycota and Basidiomycota.

Citing Articles

Impacts of Helicobacter pylori infection and eradication on gastrointestinal microbiota: An up-to-date critical review and future perspectives.

Li Y, He C, Lu N Chin Med J (Engl). 2024; 137(23):2833-2842.

PMID: 39501846 PMC: 11649276. DOI: 10.1097/CM9.0000000000003348.


Alterations of the duodenal mucosal microbiome in patients with metabolic dysfunction-associated steatotic liver disease.

Ren M, Pan H, Zhou X, Yu M, Ji F Sci Rep. 2024; 14(1):9124.

PMID: 38643212 PMC: 11032335. DOI: 10.1038/s41598-024-59605-3.


Therapeutic Approach Targeting Gut Microbiome in Gastrointestinal Infectious Diseases.

Han Z, Min Y, Pang K, Wu D Int J Mol Sci. 2023; 24(21).

PMID: 37958637 PMC: 10650060. DOI: 10.3390/ijms242115654.


Duodenal microbiota and weight-loss following sleeve gastrectomy and Roux-en-Y gastric bypass - a pilot study.

Stefura T, Rusinek J, Zajac M, Zapala B, Gosiewski T, Sroka-Oleksiak A BMC Surg. 2023; 23(1):173.

PMID: 37365522 PMC: 10291748. DOI: 10.1186/s12893-023-02076-6.


The emerging role of the small intestinal microbiota in human health and disease.

Ruigrok R, Weersma R, Vich Vila A Gut Microbes. 2023; 15(1):2201155.

PMID: 37074215 PMC: 10120449. DOI: 10.1080/19490976.2023.2201155.